Kuros Biosciences AG (SWX:KURN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
18.63
-0.22 (-1.17%)
Oct 2, 2026, 5:30 PM CET

Kuros Biosciences AG Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Kuros Biosciences AG stock has a consensus rating of "Strong Buy" and an average price target of CHF 34.29. The average 1-year stock price forecast is 84.06% higher than the current stock price, while the lowest is CHF 32.00 (+71.77%) and the highest is CHF 38.00 (+103.97%).

Price Target: CHF 34.29 (+84.06%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
PriceCHF 32.00CHF 34.29CHF 32.86CHF 38.00
Change+71.77%+84.06%+76.38%+103.97%
* Price targets were last updated on Aug 14, 2026.

Analyst Ratings

The average analyst rating for Kuros Biosciences AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy111333
Buy111110
Hold000000
Sell000000
Strong Sell000000
Total222443

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Buy
Maintains
CHF 33.00
BuyMaintainsCHF 33.00+77.13%Aug 14, 2026
Berenberg Bank
Berenberg Bank
Buy
Initiates
CHF 32.00
BuyInitiatesCHF 32.00+71.77%Jul 8, 2026
Kepler Capital
Kepler Capital
Buy
Maintains
CHF 38.00
BuyMaintainsCHF 38.00+103.97%Apr 14, 2026

Financial Forecast

Revenue This Year
213.90M
from 146.06M
Increased by 46.45%
Revenue Next Year
277.13M
from 213.90M
Increased by 29.56%
EPS This Year
0.35
from 0.06
Increased by 482.63%
EPS Next Year
0.62
from 0.35
Increased by 77.15%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
15.15M19.45M39.86M85.16M146.06M213.90M
Revenue Growth
231.96%28.35%104.92%113.65%71.51%46.45%
Gross Profit
11.04M15.54M33.81M75.67M127.45M186.41M
Gross Margin
72.86%79.89%84.83%88.85%87.26%87.15%
Operating Income
-9.62M-10.65M-6.04M120.00K8.95M16.86M
Net Income
-8.27M-15.78M-16.30M-4.84M2.55M11.97M
EPS
----0.060.35
EPS Growth
-----482.63%
Forward PE
----80.2364.57
Free Cash Flow
-----2.88M-13.55M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High223.0M
Avg213.9M
Low202.1M

Revenue Growth

Revenue Growth202620272028
High
52.7%
Avg
46.4%
Low
38.3%

EPS Forecast

EPS202620272028
High0.52
Avg0.35
Low0.19

EPS Growth

EPS Growth202620272028
High
771.8%
Avg
482.6%
Low
222.1%